Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in AMGN — Amgen Inc

CIK 72971 SAN FRANCISCO, CA
Back to AMGN Full portfolio

Position in AMGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,620,105,497
+$126,189,182 QoQ
Shares Held
7,235,462
+2.1% QoQ
Ownership
1.34%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#10
of 3,131 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in AMGN Over Time

Shares Held

Position Value (USD)

Derivatives in AMGN

reported options exposure · as of Jun 30, 2026
CallValue
$0
CallShares
0
PutValue
$760,452
PutShares
2,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $19,103,501,096 across 19 Drug Manufacturers - General names. AMGN ranks #3 (13.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 LLY
ELI LILLY & Co
 4,646,119 $5,572,694,974
2 JNJ
Johnson & Johnson
 17,374,433 $4,412,584,747
3 AMGN
Amgen Inc
This page 		7,235,462 $2,620,105,497
4 ABBV
AbbVie Inc.
 9,017,580 $2,269,183,828
5 MRK
Merck & Co., Inc.
 11,658,434 $1,498,108,767
6 GILD
Gilead Sciences, Inc.
 6,439,586 $813,577,293
7 PFE
Pfizer Inc
 20,193,675 $486,263,691
8 BMY
Bristol Myers Squibb Co
 6,321,643 $364,253,067

All Filings in AMGN

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $760,452 2,100
2026-06-30 $2,620,105,497 7,235,462
2026-03-31 $2,493,916,315 7,088,010
2026-03-31 $738,885 2,100
2025-12-31 $2,327,400,922 7,110,693
2025-12-31 $687,351 2,100
2025-09-30 $2,019,810,658 7,157,373
2025-09-30 $338,640 1,200
2025-06-30 $2,041,292,860 7,310,959
2025-06-30 $33,561,042 120,200
2025-03-31 $778,875 2,500
2025-03-31 $2,259,199,214 7,251,482
2025-03-31 $218,085 700
2024-12-31 $1,859,563,445 7,134,605
2024-12-31 $938,304 3,600
2024-09-30 $1,159,956 3,600
2024-09-30 $2,413,410,895 7,490,180
2024-06-30 $937,350 3,000
2024-06-30 $2,398,862,680 7,677,589
2024-03-31 $2,133,162,543 7,502,682
2024-03-31 $1,876,512 6,600
2024-03-31 $1,336,304 4,700
2023-12-31 $172,812 600
2023-12-31 $2,156,917,549 7,488,777
2023-12-31 $1,238,486 4,300
2023-09-30 $2,391,964 8,900
2023-09-30 $2,037,582,167 7,581,419
2023-09-30 $161,256 600
2023-06-30 $1,703,051,698 7,670,713
2023-06-30 $2,930,664 13,200
2023-06-30 $133,212 600
2023-03-31 $1,830,612,952 7,572,339
2023-03-31 $4,448,200 18,400
2023-03-31 $1,474,675 6,100
2022-12-31 $1,076,824 4,100
2022-12-31 $9,507,568 36,200
2022-12-31 $1,941,792,856 7,393,363
2022-09-30 $14,177,660 62,900
2022-09-30 $1,689,588,705 7,495,957
2022-06-30 $1,826,915,124 7,508,899
2022-06-30 $8,977,770 36,900
2022-03-31 $8,923,158 36,900
2022-03-31 $1,839,633,073 7,607,448
2021-12-31 $1,498,922,239 6,662,765
2021-09-30 $1,474,198,673 6,932,512
2021-06-30 $1,737,351,279 7,127,595
2021-03-31 $1,866,075 7,500
2021-03-31 $1,900,561,803 7,638,607
2020-12-31 $1,750,408,085 7,613,118
2020-12-31 $2,299 10

Report a Problem

Category
Description
Email (optional, for follow-up)